The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals
Abstract
In addition to metabolic differences, the anatomical, physiological, and biochemical differences in the gastrointestinal (G.I.) tract of the human and common laboratory animals can cause significant variation in drug absorption from the oral route. Among the physiological factors, pH, bile, pancreatic juice, and mucus and fluid volume and content can modify dissolution rates, solubility, transit times, and membrane transport of drug molecules. The microbial content of the G.I. tract can significantly affect the reductive metabolism and enterohepatic circulation of drugs and colonic delivery of formulations. The transit time of dosage forms can be significantly different between species due to different dimensions and propulsive activities of the G.I. tract. The lipid/protein composition of the enterocyte membrane along the G.I. tract can alter binding and passive, active, and carrier‐mediated transport of drugs. The location and number of Peyer's patches can also be important in the absorption of large molecules and particulate matter. While small animals, rats, mice, guinea pigs, and rabbits, are most suitable for determining the mechanism of drug absorption and bioavailability values from powder or solution formulations, larger animals, dogs, pigs, and monkeys, are used to assess absorption from formulations. The understanding of physiological, anatomical, and biochemical differences between the G.I. tracts of different animal species can lead to the selection of the correct animal model to mimic the bioavailability of compounds in the human. This article reviews the anatomical, physiological, and biochemical differences between the G.I. tracts of humans and commonly used laboratory animals.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dukes' Physiology of Domestic Animals
Heath, T. (1994) · Australian Veterinary Journal · doi:10.1111/j.1751-0813.1994.tb03389.x · Cited by 1,355
Geigy, J. R. (1981) · Medical Entomology and Zoology · Cited by 1,221
Transit of pharmaceutical dosage forms through the small intestine.
Davis, S. S., Hardy, J. G., & Fara, J. W. (1986) · Gut · doi:10.1136/gut.27.8.886 · Cited by 853
Owen, R. L., & Jones, A. L. (1974) · Gastroenterology · doi:10.1016/s0016-5085(74)80102-2 · Cited by 762
The Biology of the Laboratory Rabbit
(1974) · Elsevier eBooks · doi:10.1016/c2013-0-11681-9 · Cited by 618
Observations on the flora of the alimentary tract of animals and factors affecting its composition
Smith, H. W. (1965) · The Journal of Pathology and Bacteriology · doi:10.1002/path.1700890112 · Cited by 451
Ionic constituents and osmolality of gastric and small-intestinal fluids after eating
Fordtran, J. S., & Locklear, T. W. (1966) · The American Journal of Digestive Diseases · doi:10.1007/bf02233563 · Cited by 418
Cornes, J. S. (1965) · Gut · doi:10.1136/gut.6.3.225 · Cited by 389
Mucus and bicarbonate secretion in the stomach and their possible role in mucosal protection.
Allen, A., & Garner, A. (1980) · Gut · doi:10.1136/gut.21.3.249 · Cited by 363
INTESTINAL TRANSPORT OF ANTIBODIES IN THE NEWBORN RAT
Rodewald, R. (1973) · The Journal of Cell Biology · doi:10.1083/jcb.58.1.189 · Cited by 347
Cited by
Oral drug delivery with polymeric nanoparticles: The gastrointestinal mucus barriers
Ensign, L. M., Cone, R., & Hanes, J. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.12.009 · Cited by 1,623
pH-Responsive Nanoparticles for Drug Delivery
Gao, W., Chan, J. M., & Farokhzad, O. C. (2010) · Molecular Pharmaceutics · doi:10.1021/mp100253e · Cited by 1,025
Surface area of the digestive tract – revisited
Helander, H. F., & Fändriks, L. (2014) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2014.898326 · Cited by 860
Ding, X., & Kaminsky, L. S. (2003) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.43.100901.140251 · Cited by 822
Comparison of Five In Vitro Digestion Models To Study the Bioaccessibility of Soil Contaminants
Oomen, A. G., Hack, A., Minekus, M., Zeijdner, E., Cornelis, C., Schoeters, G., Verstraete, W., Van de Wiele, T., Wragg, J., Rompelberg, C. J. M., et al. (2002) · Environmental Science & Technology · doi:10.1021/es010204v · Cited by 800
Microencapsulation of probiotics for gastrointestinal delivery
Cook, M. T., Tzortzis, G., Charalampopoulos, D., & Khutoryanskiy, V. V. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.06.003 · Cited by 756
Enterohepatic Circulation: Physiological, Pharmacokinetic and Clinical Implications
Roberts, M. S., Magnusson, B. M., Burczynski, F. J., & Weiss, M. (2002) · Clinical Pharmacokinetics · doi:10.2165/00003088-200241100-00005 · Cited by 664
McConnell, E. L., Basit, A. W., & Murdan, S. (2008) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.60.1.0008 · Cited by 654
Alginate/Chitosan Nanoparticles are Effective for Oral Insulin Delivery
Sarmento, B., Ribeiro, A., Veiga, F., Sampaio, P., Neufeld, R., & Ferreira, D. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9367-4 · Cited by 617
Microbial Ecology along the Gastrointestinal Tract
Hillman, E. T., Lu, H., Yao, T., & Nakatsu, C. H. (2017) · Microbes and environments · doi:10.1264/jsme2.me17017 · Cited by 580
Van den Mooter, G. (2012) · Drug Discovery Today: Technologies · doi:10.1016/j.ddtec.2011.10.002 · Cited by 577
Amino acid metabolism in intestinal bacteria: links between gut ecology and host health
Dai, Z.-L. (2011) · Frontiers in Bioscience · doi:10.2741/3820 · Cited by 564
Colon-specific drug delivery: new approaches and in vitro/in vivo evaluation
Yang, L., Chu, J. S., & Fix, J. A. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00004-2 · Cited by 562
Nanoparticles for oral delivery: Design, evaluation and state-of-the-art
Date, A. A., Hanes, J., & Ensign, L. M. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.06.016 · Cited by 539
Progress in microencapsulation of probiotics: A review
Yao, M., Xie, J., Du, H., McClements, D. J., Xiao, H., & Li, L. (2020) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.12532 · Cited by 532
Anatomical and physiological parameters affecting gastrointestinal absorption in humans and rats
DeSesso, J. M., & Jacobson, C. F. (2001) · Food and Chemical Toxicology · doi:10.1016/s0278-6915(00)00136-8 · Cited by 528
Hua, S. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00524 · Cited by 527
Materials for oral delivery of proteins and peptides
Brown, T. D., Whitehead, K. A., & Mitragotri, S. (2019) · Nature Reviews Materials · doi:10.1038/s41578-019-0156-6 · Cited by 520
Oral lipid-based drug delivery systems – an overview
Kalepu, S., Manthina, M., & Padavala, V. (2013) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2013.10.001 · Cited by 494
Profiling the human intestinal environment under physiological conditions
Shalon, D., Culver, R. N., Grembi, J. A., Folz, J., Treit, P. V., Shi, H., Rosenberger, F. A., Dethlefsen, L., Meng, X., Yaffe, E., et al. (2023) · Nature · doi:10.1038/s41586-023-05989-7 · Cited by 484
Lundquist, P., & Artursson, P. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.07.007 · Cited by 483
PEGylation for enhancing nanoparticle diffusion in mucus
Huckaby, J. T., & Lai, S. K. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.08.010 · Cited by 461
Chitosan and its derivatives as intestinal absorption enhancers
Thanou, M., Verhoef, J. C., & Junginger, H. E. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00180-6 · Cited by 430
Expandable gastroretentive dosage forms
Klausner, E. A., Lavy, E., Friedman, M., & Hoffman, A. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00203-7 · Cited by 419
Stimuli-responsive nanomaterials for therapeutic protein delivery
Lu, Y., Sun, W., & Gu, Z. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.08.015 · Cited by 415
Nanoparticle toxicity by the gastrointestinal route: evidence and knowledge gaps
Bergin, I. L., & Witzmann, F. A. (2013) · International Journal of Biomedical Nanoscience and Nanotechnology · doi:10.1504/ijbnn.2013.054515 · Cited by 412
Assessing the performance of amorphous solid dispersions
Newman, A., Knipp, G., & Zografi, G. (2012) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23031 · Cited by 406
Alternative Sigma Factors and Their Roles in Bacterial Virulence
Kazmierczak, M. J., Wiedmann, M., & Boor, K. J. (2005) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.69.4.527-543.2005 · Cited by 404
A glutamate decarboxylase system protects Listeria monocytogenes in gastric fluid
Cotter, P. D., Gahan, C. G. M., & Hill, C. (2001) · Molecular Microbiology · doi:10.1046/j.1365-2958.2001.02398.x · Cited by 388
Mucus as a Barrier to Drug Delivery – Understanding and Mimicking the Barrier Properties
Boegh, M., & Nielsen, H. M. (2015) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12342 · Cited by 384
Dąbrowska, K. (2019) · Medicinal Research Reviews · doi:10.1002/med.21572 · Cited by 375
De Matteis, V. (2017) · Toxics · doi:10.3390/toxics5040029 · Cited by 362
Emerging Trends in Oral Delivery of Peptide and Protein Drugs
Mahato, R. I., Narang, A. S., Thoma, L., & Miller, D. D. (2003) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v20.i23.30 · Cited by 352
Nanoparticle approaches against bacterial infections
Gao, W., Thamphiwatana, S., Angsantikul, P., & Zhang, L. (2014) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1282 · Cited by 347
Oral exposure to polystyrene nanoparticles affects iron absorption
Mahler, G. J., Esch, M. B., Tako, E., Southard, T. L., Archer, S. D., Glahn, R. P., & Shuler, M. L. (2012) · Nature Nanotechnology · doi:10.1038/nnano.2012.3 · Cited by 340
Drivers of Microbiome Biodiversity: A Review of General Rules, Feces, and Ignorance
Reese, A. T., & Dunn, R. R. (2018) · mBio · doi:10.1128/mbio.01294-18 · Cited by 325
Current methodologies used for evaluation of intestinal permeability and absorption
Balimane, P. V., Chong, S., & Morrison, R. A. (2000) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/s1056-8719(00)00113-1 · Cited by 319
Maisel, K., Ensign, L., Reddy, M., Cone, R., & Hanes, J. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.10.026 · Cited by 319
Mimicking the Cell: Bio-Inspired Functions of Supramolecular Assemblies
Tu, Y., Peng, F., Adawy, A., Men, Y., Abdelmohsen, L. K. E. A., & Wilson, D. A. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00344 · Cited by 316
O'Driscoll, C. M., & Griffin, B. T. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.10.012 · Cited by 296
Models for oral uptake of nanoparticles in consumer products
Fröhlich, E., & Roblegg, E. (2012) · Toxicology · doi:10.1016/j.tox.2011.11.004 · Cited by 295
Foundations of gastrointestinal-based drug delivery and future developments
Chu, J. N., & Traverso, G. (2022) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00539-w · Cited by 289
Bélteky, P., Rónavári, A., Igaz, N., Szerencsés, B., Tóth, I. Y., Pfeiffer, I., Kiricsi, M., & Kónya, Z. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s185965 · Cited by 288
Timchalk, C. (2002) · Toxicological Sciences · doi:10.1093/toxsci/66.1.34 · Cited by 285
Prediction of ADMET Properties
Norinder, U., & Bergström, C. A. S. (2006) · ChemMedChem · doi:10.1002/cmdc.200600155 · Cited by 285
Sjögren, E., Abrahamsson, B., Augustijns, P., Becker, D., Bolger, M. B., Brewster, M., Brouwers, J., Flanagan, T., Harwood, M., Heinen, C., et al. (2014) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2014.02.010 · Cited by 279
Chitosans as absorption enhancers of poorly absorbable drugs
Schipper, N. G. M., Vårum, K. M., Stenberg, P., Ocklind, G., Lennernäs, H., & Artursson, P. (1999) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(99)00032-9 · Cited by 278
Intestinal lymphatic transport for drug delivery
Yáñez, J. A., Wang, S. W. J., Knemeyer, I. W., Wirth, M. A., & Alton, K. B. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.05.019 · Cited by 278
Porcine models of digestive disease: the future of large animal translational research
Gonzalez, L. M., Moeser, A. J., & Blikslager, A. T. (2015) · Translational Research · doi:10.1016/j.trsl.2015.01.004 · Cited by 276
Amorphous Solid Dispersions: Utilization and Challenges in Drug Discovery and Development
He, Y., & Ho, C. (2015) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24541 · Cited by 272
Polymeric nanoparticle drug delivery technologies for oral delivery applications
Pridgen, E. M., Alexis, F., & Farokhzad, O. C. (2015) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2015.1018175 · Cited by 269
Calcium alginate-carboxymethyl cellulose beads for colon-targeted drug delivery
Agarwal, T., Narayana, S. N. G. H., Pal, K., Pramanik, K., Giri, S., & Banerjee, I. (2015) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2014.12.052 · Cited by 260
Kinetic Study of Catechin Stability: Effects of pH, Concentration, and Temperature
Li, N., Taylor, L. S., Ferruzzi, M. G., & Mauer, L. J. (2012) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf304116s · Cited by 258
Membrane Transport of Drugs in Different Regions of the Intestinal Tract of the Rat
Ungell, A.-L., Nylander, S., Bergstrand, S., Sjöberg, Å., & Lennernäs, H. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js970218s · Cited by 257
Early pharmaceutical profiling to predict oral drug absorption: Current status and unmet needs
Bergström, C. A. S., Holm, R., Jørgensen, S. A., Andersson, S. B. E., Artursson, P., Beato, S., Borde, A., Box, K., Brewster, M., Dressman, J., et al. (2014) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2013.10.015 · Cited by 257
Nano- and microparticulate drug carriers for targeting of the inflamed intestinal mucosa
Collnot, E.-M., Ali, H., & Lehr, C.-M. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.01.028 · Cited by 254
Gonzalez, L. M., Moeser, A. J., & Blikslager, A. T. (2015) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00112.2013 · Cited by 252
Genetically engineered pigs as models for human disease
Perleberg, C., Kind, A., & Schnieke, A. (2018) · Disease Models & Mechanisms · doi:10.1242/dmm.030783 · Cited by 222
Hatton, G. B., Yadav, V., Basit, A. W., & Merchant, H. A. (2015) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24365 · Cited by 204
Chiou, W. L., Jeong, H. Y., Chung, S. M., & Wu, T. C. (2000) · Pharmaceutical Research · doi:10.1023/a:1007552927404 · Cited by 182
Recent advances in colon drug delivery systems
Arévalo-Pérez, R., Maderuelo, C., & Lanao, J. M. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.09.026 · Cited by 179
Vertebrate Gastrointestinal System
Karasov, W. H., & Hume, I. D. (1997) · Comprehensive Physiology · doi:10.1002/cphy.cp130107 · Cited by 170
The role of serotonin in intestinal luminal sensing and secretion
Hansen, M. B., & Witte, A. ‐. (2008) · Acta Physiologica · doi:10.1111/j.1748-1716.2008.01870.x · Cited by 144
Thelen, K., Coboeken, K., Willmann, S., Burghaus, R., Dressman, J. B., & Lippert, J. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22726 · Cited by 139
Salphati, L., Childers, K., Pan, L., Tsutsui, K., & Takahashi, L. (2001) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357011776252 · Cited by 132
McKim, J. M. (2014) · Critical Reviews in Toxicology · doi:10.3109/10408444.2013.861797 · Cited by 108
Oral systemic bioavailability of bisphenol A and bisphenol S in pigs.
Gayrard, V., Lacroix, M. Z., Grandin, F. C., Collet, S. H., Mila, H., Viguié, C., Gély, C. A., Rabozzi, B., Bouchard, M., Léandri, R., et al. (2019) · Environmental Health Perspectives · doi:10.1289/ehp4599 · Cited by 99
He, Z., Hu, Y., Niu, Z., Zhong, K., Liu, T., Yang, M., Ji, L., & Hu, W. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.115865 · Cited by 93
Modeling the pH-dependent PLA oligomer degradation kinetics
Lazzari, S., Codari, F., Storti, G., Morbidelli, M., & Moscatelli, D. (2014) · Polymer Degradation and Stability · doi:10.1016/j.polymdegradstab.2014.08.012 · Cited by 61
Kagan, L., & Hoffman, A. (2008) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.5.6.681 · Cited by 60
Abdallah, A., Elemba, E., Zhong, Q., & Sun, Z. (2020) · Current Protein & Peptide Science · doi:10.2174/1389203721666200212095503 · Cited by 59
Prospective Predictions of Human Pharmacokinetics for Eighteen Compounds
Zhang, T., Heimbach, T., Lin, W., Zhang, J., & He, H. (2015) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24373 · Cited by 56
Buckwheat and CVD Risk Markers: A Systematic Review and Meta-Analysis
(2018) · doi:10.3390/nu10050619 · Cited by 50
van Kessel, S. P., Bullock, A., van Dijk, G., & El Aidy, S. (2022) · mSystems · doi:10.1128/msystems.01191-21 · Cited by 41
Gastrointestinal safety pharmacology in drug discovery and development
Al-Saffar, A., da Costa, A. N., Delaunois, A., Leishman, D. J., Marks, L., Rosseels, M.-L., & Valentin, J.-P. (2015) · Handbook of experimental pharmacology · doi:10.1007/978-3-662-46943-9_12 · Cited by 29
Palus, K., & Całka, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms21010015 · Cited by 22
Ziegler, A. L., & Blikslager, A. T. (2017) · Neurogastroenterology & Motility · doi:10.1111/nmo.13216 · Cited by 9
Metadata
- Authors
- Kararli, T. T.
- Venue
- Biopharmaceutics & Drug Disposition
- Publisher
- Wiley
- Published
- 1995-07
- Volume
- 16
- Issue
- 5
- Pages
- 351-380
- ISSN
- 0142-2782 (ISSN-L)
- 1099-081X
- OpenAlex
- W2018445772
- Cited by
- 1,459
- References
- 59
- FWCI
- 11.89
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.